Acurx Share Price

Acurx Share Price

NASDAQ: ACXP | Micro Cap | Healthcare
$0.99
+$0.01 (1.02%) Last updated on 19 Nov, 2026 | 02:19 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Acurx Stock Performance

Open
$0.97
Prev. Close
$0.98
Circuit Range
N/A
Day Range
$0.97 - $1.01
Year Range
$0.93 - $7.50
Volume
691
Average Traded
$1.00

Acurx Share Price Today

As of 19 November 2026, Acurx Pharmaceuticals, Inc.'s share price is $0.99. The stock opened at $0.97, compared to its previous close of $0.98. During today's trading session, Acurx Pharmaceuticals, Inc.'s share price traded between $0.97 and $1.01, with an average price of $0.99. Over the past 52 weeks, the stock has recorded a high of $7.50 and a low of $0.93. In terms of performance, Acurx Pharmaceuticals, Inc.'s share price has declined by 49.75% over the last six months and is down 74.39% on a year-on-year basis.

Acurx Share Price Chart

Line chart of the Acurx price trend over the selected period. The price rose overall, ranging from 0.97 to 1.01, ending at 0.99.
$0.97$1.01
L
Show Current Price
H

Acurx Stock Fundamentals & Key Indicators

Market Cap
$1.48M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.48
Revenue (TTM)
$0.00
Return On Equity (TTM)
-110.25%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-63.29%

Acurx Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$1.58-$1.68-$2.25-$2.58
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-6.33%-33.93%-14.67%

Acurx Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$12.09-$14.58-$14.10-$7.97
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-20.60%3.29%43.48%

Acurx Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.00.00.00.0
Current Assets7.693.867.719.38
Total Assets7.693.867.719.38
Non Current Liabilities0.00.00.00.0
Current Liabilities2.423.243.042.06
Total Liabilities2.423.243.042.06
Shareholders' Equity5.270.624.677.32

Acurx Cash Flow

Annually
Particulars2025202420232022
Operating (USD Million)-6.79-10.38-9.8-7.54
Investing (USD Billion)0.00.00.00.0
Financing (USD Million)10.646.628.163.7

Corporate Actions

Split
Ex-date: 05 Aug 2025

About Acurx

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

Acurx Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.08
$0.99
-4.81%
Oct 2026
$1.25
$1.04
-18.11%
Sep 2026
$1.41
$1.27
-12.11%
Aug 2026
$1.42
$1.45
+3.58%
Jul 2026
$1.53
$1.40
-9.71%
Jun 2026
$1.93
$1.54
-21.57%
May 2026
$2.18
$1.97
-8.80%
Apr 2026
$3.73
$2.16
-41.30%
Mar 2026
$1.46
$3.68
+146.98%
Feb 2026
$2.44
$1.49
-37.13%
Jan 2026
$2.75
$2.37
-13.82%
Dec 2025
$3.68
$2.75
-28.85%

Acurx Share Price FAQs